The synergy between alkylating agents and ERCC1-XPF inhibitors is p53 dependent.
- DOI
- 10.1111/fcp.13043
- Published
- 2025 Feb
- Container
- Fundamental & clinical pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/fcp.13043,
title = {The synergy between alkylating agents and ERCC1-XPF inhibitors is p53 dependent.},
author = {Ciniero G and Pedro TM and Dumontet C and Elmenoufy AH and West FG and Weinfeld M and Gentile F and Tuszynski JA and Cros-Perrial E and Jordheim LP},
year = {2025},
journal = {Fundamental \& clinical pharmacology},
doi = {10.1111/fcp.13043},
url = {https://doi.org/10.1111/fcp.13043}
}RIS
TY - JOUR TI - The synergy between alkylating agents and ERCC1-XPF inhibitors is p53 dependent. AU - Ciniero G AU - Pedro TM AU - Dumontet C AU - Elmenoufy AH AU - West FG AU - Weinfeld M AU - Gentile F AU - Tuszynski JA AU - Cros-Perrial E AU - Jordheim LP PY - 2025 JO - Fundamental & clinical pharmacology DO - 10.1111/fcp.13043 UR - https://doi.org/10.1111/fcp.13043 ER -
APA
G, C., TM, P., C, D., AH, E., FG, W., M, W., F, G., JA, T., E, C., & LP, J. (2025). The synergy between alkylating agents and ERCC1-XPF inhibitors is p53 dependent.. Fundamental & clinical pharmacology. https://doi.org/10.1111/fcp.13043
Source records
- pubmed · retrieved 2026-09-27T08:09:37.478Z